Jafron Biomedical Co

Jafron Biomedical Co Inventory

The Inventory of Jafron Biomedical Co (300529.SZ) as of Nov 6, 2026 is 291.75 M CNY. In the previous year, Inventory was 337.79 M CNY — a change of -13.63% (lower).

Inventory

291.75 MCNY

YoY

-13.63%

Last updated:

Inventory of Jafron Biomedical Co is 2025 291.75 M CNY. Inventory of Jafron Biomedical Co was 2024 337.79 M CNY. It decreases by -13.63% lower compared to the previous year.

The Jafron Biomedical Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
61.16 M CNY
Jan 1, 2019
92.31 M CNY
Jan 1, 2020
120.67 M CNY
Jan 1, 2021
196.55 M CNY
Jan 1, 2022
349.13 M CNY
Jan 1, 2023
385.00 M CNY
Jan 1, 2024
337.79 M CNY
Jan 1, 2025
291.75 M CNY
The Jafron Biomedical Co Inventory history
YEARInventoryYoY
291.75 MCNY-13.63%
337.79 MCNY-12.26%
385.00 MCNY+10.27%
349.13 MCNY+77.63%
196.55 MCNY+62.88%
120.67 MCNY+30.72%
92.31 MCNY+50.94%
61.16 MCNY+35.19%
45.24 MCNY-10.39%
50.48 MCNY+29.41%
39.01 MCNY+11.23%
35.07 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jafron Biomedical Co Stock analysis

What does Jafron Biomedical Co do? Jafron Biomedical Co., Ltd. generates revenue through the research, development, production, and sale of hemoperfusion products and medical equipment. The company offers a range of items including disposable hemoperfusion devices, hemoperfusion machines, disposable bilirubin adsorbers, the DX-10 blood purification machine, suture needles, and resins bandage. These products are utilized for treating conditions such as uremia, poisoning, severe liver diseases, autoimmune diseases, and multisystem organ failure. The primary customers for these medical solutions are hospitals across China, where the company’s products are applied in more than 3000 hospitals within 31 provinces. As a China-based company, Jafron Biomedical Co., Ltd. focuses on the design, manufacture, and distribution of biological materials and medical equipment to support healthcare providers in these regions. The company operates from its headquarters in Zhuhai, Guangdong, and supports its operations with a workforce of 3,003 full-time employees. By engaging in the full lifecycle of its products from research to sale, the firm serves the medical sector with specialized equipment for blood purification and related therapeutic needs. Jafron Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jafron Biomedical Co stock

Inventory of Jafron Biomedical Co is 291.75 M CNY in 2025.

Inventory of Jafron Biomedical Co changed from 337.79 M CNY to 291.75 M CNY, representing a -13.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Jafron Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Jafron Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Jafron Biomedical Co

All Key Metrics — Jafron Biomedical Co